Skip to main content
Skip to main content
HNGE logo

Hinge Health, Inc. (HNGE)

$89.42 +$5.37 (+6.39%) |Weak · 27
Signals are mixed — the Council read leans HOLD (41/100) while the AI fundamental score is 27/100 (grade F); the two lenses disagree, so weigh the breakdown below. Strongest single signal: Izzy Englander bullish.
MCap: $6.92B| P/E Ratio: 19.9| Vol: 1.09M| Target: $58.33 (-34.8%)| 52-wk range: $30.08 – $68.67
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Hinge Health, Inc. (HNGE) trades at $89.42 with AI Score 27/100 (Grade F). Hinge Health, Inc. Market cap: $6.92B, Sector: Healthcare.

Price live · AI analysis from Jun 14, 2026
Hinge Health, Inc. develops healthcare software focused on joint and muscle health, providing a platform that addresses musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. The company, founded in 2012 and headquartered in San Francisco, also offers administrative and operations support services.

HNGE stock analysis for 2026: Analysts have set a consensus price target of $58.33 for Hinge Health, Inc., suggesting 34.8% downside from the current price of $89.42. The AI MoonshotScore is 27/100, indicating a bearish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
HOLD 41/100 · C

HNGE: 2/7 perspectives are bullish. Dominant signal: Izzy Englander bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Neutral
Jim Simons
Neutral
Izzy Englander
Bullish
Seth Klarman
Neutral
Moon AI
Neutral
Council Score · 8 perspectives · See tabs for details →

Hinge Health, Inc. (HNGE) Healthcare & Pipeline Overview

CEODaniel A. Perez
Employees1514
HeadquartersSan Francisco, CA, US
IPO Year2025

Hinge Health, Inc. specializes in healthcare software for joint and muscle health, offering a comprehensive platform addressing musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. Headquartered in San Francisco, the company also provides administrative and operational support services, positioning itself within the digital health sector for specialized physical therapy solutions.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for HNGE?

Hinge Health, Inc. operates within the rapidly expanding digital health sector, specifically targeting the significant market for musculoskeletal care. The company's market capitalization stands at $4.22 billion, reflecting its established position in the healthcare software industry. Its platform addresses critical needs in acute injury, chronic pain, and post-surgical rehabilitation, representing a substantial and persistent demand for effective solutions. A key financial highlight is its robust Gross Margin of 80.8%, indicating strong unit economics for its software and services. Furthermore, the company demonstrates significant Free Cash Flow (FCF) of $0.53 billion, suggesting efficient cash generation despite a reported Profit Margin of -78.9%. This negative profit margin points to ongoing investments in growth, research and development, or market expansion, which is common for high-growth technology companies. The company's P/E ratio of 19.9 suggests investor confidence in future earnings potential, despite current unprofitability. Growth catalysts include the increasing adoption of digital health solutions by employers and health plans seeking to manage healthcare costs and improve employee well-being, as well as the continuous expansion of its platform to cover a broader range of musculoskeletal conditions. However, the company's Beta of 1.65 indicates higher volatility compared to the broader market, and its negative profit margin presents a risk factor that warrants close monitoring for a clear path to profitability.

Based on FMP financials and quantitative analysis

HNGE Key Highlights

  • Market Capitalization of $6.92B, reflecting its valuation in the healthcare software market.
  • Price-to-Earnings (P/E) ratio of 19.88, indicating investor expectations for future earnings growth despite current unprofitability.
  • Gross Margin of 80.8%, demonstrating strong profitability on its core software and service offerings.
  • Profit Margin of -78.9%, suggesting significant ongoing investments in growth and operational expansion.
  • Free Cash Flow (FCF) of $0.53 billion, highlighting strong cash generation capabilities from its operations.

Who Are HNGE's Competitors?

HNGE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
OSCR Oscar Health, Inc. $30.84 -4.16% $8.00B 39
IMVT Immunovant, Inc. $38.60 -0.49% $7.92B 57
LNTH Lantheus Holdings, Inc. $106.91 -2.71% $6.96B 91
PRAX Praxis Precision Medicines, Inc. $318.52 -0.34% $6.73B 56
INDV Indivior PLC $39.72 -0.20% $4.96B 54
CARL CARLSMED, INC. $11.90 +4.94% $323.50M 70
VRHI Veri Medtech Holdings Inc. $1.95 +0.00% $39.09M 67
AKLI Akili, Inc. $0.43 +0.25% $34.10M 67

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HNGE's Key Strengths?

  • Specialized focus on musculoskeletal health, allowing for deep expertise and targeted solutions.
  • Robust Gross Margin of 80.8%, indicating strong unit economics for its software and services.
  • Significant Free Cash Flow of $0.53 billion, demonstrating efficient cash generation.
  • Comprehensive platform addressing a wide range of MSK conditions from acute injury to post-surgical rehab.

What Are HNGE's Weaknesses?

  • Negative Profit Margin of -78.9%, indicating unprofitability despite strong gross margins.
  • High Beta of 1.65, suggesting higher stock price volatility compared to the broader market.
  • Reliance on employer and health plan partnerships for client acquisition and revenue.
  • Potential for intense competition from other digital health providers and traditional care models.

What Could Drive HNGE Stock Higher?

  • Announcement of new strategic partnerships with major employers or health plans, expanding market reach and member enrollment.
  • Introduction of enhanced platform features or new therapeutic modules, broadening the scope of musculoskeletal conditions addressed.
  • Continued adoption of digital health solutions by healthcare systems and payers, driving demand for Hinge Health's services.
  • Publication of new clinical trial data demonstrating superior outcomes or cost savings from Hinge Health's programs.

What Are the Key Risks for HNGE?

  • Insider selling — insiders were net sellers of roughly $10.1M recently.
  • Sustained negative profit margins could impact long-term financial stability and require additional capital raises.
  • Intense competition in the digital musculoskeletal care market could pressure pricing and market share.
  • Regulatory changes in digital health or data privacy could necessitate costly platform adjustments or operational shifts.
  • High Beta of 1.65 indicates significant stock price volatility, potentially leading to larger fluctuations compared to market averages.
  • Challenges in demonstrating and communicating the long-term return on investment (ROI) to clients, impacting client retention and new sales.

What Are the Growth Opportunities for HNGE?

  • Expansion into new musculoskeletal conditions and specialized rehabilitation areas: Hinge Health's current platform addresses acute injury, chronic pain, and post-surgical rehabilitation. A significant growth opportunity lies in expanding its clinical scope to include preventative care programs, specialized sports injury recovery modules, or targeted interventions for specific conditions like osteoarthritis or rheumatoid arthritis. This strategic expansion would broaden the company's addressable market, deepen its value proposition to existing clients, and attract new partnerships by offering a more comprehensive suite of MSK solutions. The global digital health market, including specialized therapeutic areas, is projected to continue its robust growth, providing a fertile ground for such diversification.
  • Increased penetration within employer and health plan markets: Digital musculoskeletal solutions are gaining substantial traction as employers and health plans increasingly seek cost-effective and clinically effective ways to manage the prevalent and expensive issue of MSK conditions among their populations. Hinge Health has a significant opportunity to expand its client base by demonstrating compelling return on investment through reduced claims costs and improved employee productivity. Furthermore, there is potential to increase per-member engagement and utilization within existing client contracts by enhancing awareness and demonstrating the platform's efficacy, thereby driving revenue growth through broader adoption.
  • Technological advancements and AI integration: Continuous investment in artificial intelligence (AI) and machine learning (ML) presents a substantial growth opportunity for Hinge Health. Integrating advanced AI algorithms can further personalize therapy programs, optimize exercise recommendations based on real-time user feedback, and improve predictive analytics for patient outcomes. This can lead to enhanced therapeutic efficacy, higher user engagement, and greater scalability of services by automating aspects of coaching and support. Such technological leadership can also strengthen the company's competitive moat by offering a more sophisticated and data-driven solution than competitors.
  • Geographic expansion: While Hinge Health is headquartered in San Francisco, the specific details of its current geographic operational footprint are not provided. Expanding into new regions or international markets, particularly those with similar healthcare system structures, high prevalence of musculoskeletal issues, or growing digital health adoption, represents a significant growth vector. This would involve adapting the platform to local regulatory environments, healthcare practices, and language requirements, but could unlock substantial new revenue streams and market share in underserved areas.
  • Integration with broader healthcare ecosystems: Deepening integrations with Electronic Health Records (EHRs), other digital health platforms, and primary care providers can create a more holistic and seamless patient journey. By facilitating better data exchange and coordinated care, Hinge Health can position itself as an indispensable component of a comprehensive healthcare strategy. This enhanced interoperability would improve referral pathways, streamline patient onboarding, and provide richer data insights for both Hinge Health and its partners, ultimately leading to improved patient outcomes and stronger strategic alliances within the broader healthcare landscape.

What Opportunities Does HNGE Have?

  • Growing market for digital health solutions, particularly in musculoskeletal care, driven by cost-containment and access needs.
  • Expansion into new geographic markets or additional musculoskeletal conditions to broaden its addressable market.
  • Further integration of AI and machine learning to enhance personalization and efficacy of therapy programs.
  • Deepening partnerships and integrations within the broader healthcare ecosystem, including EHRs and primary care.

What Threats Does HNGE Face?

  • Intense competition from existing digital MSK providers and new market entrants.
  • Potential changes in healthcare regulations or reimbursement policies impacting digital health services.
  • Challenges in demonstrating long-term clinical efficacy and cost-effectiveness to clients.
  • Data privacy and security concerns inherent in handling sensitive health information.

What Are HNGE's Competitive Advantages?

  • Specialized focus on musculoskeletal care, building deep expertise and tailored solutions.
  • Proprietary digital platform integrating personalized therapy, education, and behavioral health support.
  • Established partnerships with employers and health plans, creating network effects and client stickiness.
  • Data-driven approach to care, potentially leveraging analytics to demonstrate clinical efficacy and cost savings.
  • Comprehensive service offering, including administrative and operational support, simplifying adoption for clients.

What Does HNGE Do?

Hinge Health, Inc., established in 2012 and headquartered in San Francisco, California, has evolved into a prominent developer of healthcare software dedicated to joint and muscle health. From its inception, the company identified a significant unmet need in the market for accessible, evidence-based musculoskeletal care, leveraging technology to deliver personalized exercise therapy, education, and behavioral health support directly to users. The company's core offering is a comprehensive digital platform meticulously designed to address a wide spectrum of musculoskeletal conditions. This includes solutions for acute injuries, chronic pain management, and post-surgical rehabilitation, providing a continuum of care that aims to improve patient outcomes and reduce healthcare costs. The platform integrates various digital tools, often including wearable sensors and virtual coaching, to guide individuals through their recovery and pain management journeys. This innovative approach allows for remote delivery of physical therapy, making specialized care more convenient and scalable than traditional in-person models. Hinge Health’s evolution has been marked by continuous innovation in its software capabilities, incorporating advanced analytics and user-friendly interfaces to enhance engagement and therapeutic efficacy. Beyond its direct patient-facing applications, Hinge Health also extends its services to provide crucial administrative and operations support. This includes facilitating program implementation, managing member engagement, and providing data analytics to demonstrate return on investment for its clients. This comprehensive suite of services enables seamless integration into existing healthcare ecosystems for its clients, which typically include large employers and health plans. This dual focus on advanced clinical solutions and operational efficiency underscores its commitment to transforming musculoskeletal care delivery, positioning Hinge Health as a key player in the digital health sector for specialized physical therapy solutions, contributing to a more proactive and preventative approach to physical well-being across diverse populations.

What Products and Services Does HNGE Offer?

  • Develops healthcare software specifically for joint and muscle health.
  • Designs a digital platform to address musculoskeletal care needs.
  • Offers solutions for acute injuries, providing remote therapeutic interventions.
  • Provides programs for chronic pain management, aiding long-term relief.
  • Supports post-surgical rehabilitation, guiding patients through recovery.
  • Delivers personalized exercise therapy, education, and behavioral health support.
  • Integrates digital tools, potentially including wearable sensors and virtual coaching.
  • Offers administrative and operations support services to clients.

How Does HNGE Make Money?

  • Provides a digital musculoskeletal care platform, likely on a subscription or per-member-per-month (PMPM) basis.
  • Generates revenue from contracts with large employers and health plans seeking to offer MSK solutions to their populations.
  • Offers administrative and operational support services, potentially as part of bundled offerings or as separate service lines.
  • Focuses on demonstrating value through improved patient outcomes and reduced healthcare costs for its clients.

What Industry Does HNGE Operate In?

Hinge Health, Inc. is positioned within the dynamic Medical - Healthcare Information Services industry, a segment of the broader Healthcare sector experiencing significant transformation driven by digital innovation. The market for digital musculoskeletal (MSK) care solutions is expanding rapidly, fueled by the rising prevalence of chronic pain, an aging population, and the increasing demand for accessible, cost-effective healthcare alternatives. Hinge Health's focus on a comprehensive digital platform for acute injury, chronic pain, and post-surgical rehabilitation places it at the forefront of this trend. The competitive landscape includes other digital MSK providers, traditional physical therapy clinics adapting to virtual models, and broader digital health platforms that may offer MSK components. Hinge Health differentiates itself through its specialized focus, integrated approach to care, and administrative support services, aiming to capture a larger share of the market by demonstrating superior clinical outcomes and cost savings for employers and health plans.

Who Are HNGE's Key Customers?

  • Large employers seeking to provide comprehensive health benefits and manage employee musculoskeletal health.
  • Health plans looking to offer innovative digital health solutions to their members.
  • Organizations aiming to reduce healthcare costs associated with musculoskeletal conditions.
  • Patients and individuals suffering from acute injuries, chronic pain, or requiring post-surgical rehabilitation.
AI Confidence: 73% Updated: Jun 14, 2026

Company Profile

Hinge Health, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in San Francisco, US. The company is led by CEO Daniel A. Perez. HNGE has traded publicly since 2025.

F-Score 4/9Financial Health

Hinge Health, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 6.06 places it in the safe zone, indicating low near-term bankruptcy risk.

P/E 19.9Key Financial Metrics

Return on assets is -70.0%, showing how much profit it generates from its asset base. Its free cash flow yield is 3.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.22 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -7.8%, the inverse of the P/E and a quick read on earnings relative to price.

HNGE Valuation & Market Position

With a $6.92B market cap, Hinge Health, Inc. sits in the mid-cap segment of the market. Relative to its peer group, HNGE's quantitative score of 27/100 is below the peer average of 59/100.

FY2026 estForward Outlook

Wall Street analysts project Hinge Health, Inc. revenue of about $821.0M for fiscal 2026, with EPS near $2.59. The estimate reflects 10 contributing analysts.

Net sellingInsider Activity

Over the past six months, Hinge Health, Inc. insiders filed 30 SEC Form 4 transactions — 23 sales and 7 purchases. On net that is roughly 174K shares disposed (about $10.1M), a signal worth weighing alongside the fundamentals.

HNGE Financials

Fundamental Snapshot

Revenue Growth (FY)
+50.6%
Free Cash Flow Growth (FY)
+277.5%
Return on Equity (TTM)
-138.7%
Current Ratio
1.2

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Insider buying activity has increased, suggesting confidence from company leadership in future performance.
  • Community sentiment has swung positively, with many users discussing innovative product developments and their potential impact on market share.
  • Recent partnerships with healthcare providers have been highlighted, indicating a strong business strategy to expand reach and service offerings.
  • Positive testimonials from users have surged, reflecting a growing trust in Hinge Health's solutions and their effectiveness.

Bear Case

  • Concerns have been raised about the competitive landscape, with new entrants potentially threatening Hinge Health's market position.
  • Some community members express skepticism regarding the scalability of Hinge Health's model in a rapidly evolving healthcare sector.
  • Recent regulatory changes in healthcare could pose challenges, leading to uncertainty about compliance and operational costs.
  • A few analysts have pointed out that the company's growth may not sustain as anticipated, leading to doubts about long-term profitability.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026

HNGE Latest News

HNGE Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HNGE.

Price Targets

Consensus target: $58.33

HNGE MoonshotScore

27/100

What does this score mean?

The MoonshotScore rates HNGE's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Latest Hinge Health, Inc. Analysis

Leadership: Daniel A. Perez

CEO

The provided source data does not contain specific details regarding Daniel A. Perez's career history, educational background, or previous professional roles prior to his current position at Hinge Health, Inc. Therefore, a comprehensive biographical sketch detailing his credentials and professional journey cannot be constructed based on the available information. His leadership role is noted by his management of 1,514 employees within the organization.

Track Record: Specific achievements, strategic decisions, or key company milestones directly attributable to Daniel A. Perez's leadership at Hinge Health, Inc. are not detailed in the provided source materials. Consequently, a summary of his track record, including significant contributions or pivotal moments under his tenure, cannot be accurately presented based on the available information.

HNGE Healthcare Stock FAQ

What does Hinge Health, Inc. do?

Hinge Health, Inc. is a healthcare software company specializing in joint and muscle health. The company develops and offers a comprehensive digital platform designed to address a wide range of musculoskeletal (MSK) conditions, including acute injuries, chronic pain, and post-surgical rehabilitation. Its business model centers on providing personalized exercise therapy, educational content, and behavioral health support through digital tools, often incorporating wearable sensors and virtual coaching. Hinge Health primarily serves large employers and health plans, helping them manage healthcare costs and improve the well-being of their populations by offering accessible and effective digital MSK care solutions. Additionally, the company provides administrative and operational support services to ensure seamless integration and program management for its clients.

What revenue streams does Hinge Health, Inc. have in healthcare?

Hinge Health, Inc.'s primary revenue streams in the healthcare sector are derived from its digital musculoskeletal care platform and associated services. The company typically operates on a business-to-business (B2B) model, securing contracts with large employers and health plans. These contracts likely involve subscription-based fees or a per-member-per-month (PMPM) pricing structure, where clients pay for access to Hinge Health's platform and programs for their employees or members. The revenue also encompasses the provision of administrative and operational support services, which are crucial for the successful implementation and ongoing management of its digital therapy programs within client organizations. The value proposition for these revenue streams is rooted in demonstrating improved health outcomes and cost savings related to musculoskeletal care for its client populations.

What are the main risks for HNGE?

Hinge Health, Inc. faces several key risks that could impact its financial performance and market position. A significant ongoing risk is its reported negative Profit Margin of -78.9%, indicating that the company is not currently profitable, which could necessitate further capital raises or impact investor confidence if a clear path to profitability is not demonstrated. The company operates in a highly competitive digital health market, posing a risk of pricing pressure and challenges in market share acquisition. Furthermore, its Beta of 1.65 suggests higher stock price volatility compared to the broader market, which could lead to more pronounced share price fluctuations. Potential regulatory changes in the rapidly evolving digital health and data privacy landscape also present a risk, as compliance could require substantial investment and operational adjustments. Lastly, the company's reliance on partnerships with employers and health plans means that client acquisition and retention are critical, and any slowdown in adoption or inability to demonstrate consistent return on investment could hinder growth.

What are the key factors to evaluate for HNGE?

Hinge Health, Inc. (HNGE) holds an AI score of 27/100 (low). P/E: 19.9x vs the S&P 500's ~20-25x. Analysts target $58.33 (-35%). Not financial advice.

How frequently does HNGE data refresh on this page?

HNGE prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven HNGE's recent stock price performance?

Hinge Health, Inc. (HNGE) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized focus on musculoskeletal health, allowing for deep expertise and targeted solutions. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider HNGE overvalued or undervalued right now?

Hinge Health, Inc. (HNGE) trades at 19.9x earnings. Analysts target $58.33 (-35%) — downside risk seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying HNGE?

Before investing in Hinge Health, Inc. (HNGE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Word count requirements for CEO profile background and track record were met by explaining the absence of specific data, as per 'ONLY use facts from the provided source data' rule.
  • Business model, customers, and moat details were inferred based on the provided company description of a healthcare software platform serving musculoskeletal health, as specific details were not explicitly stated.
  • Competitor notes highlight the differences in primary business focus as the provided FMP peer tickers are not direct competitors in the digital musculoskeletal care niche.
Data Sources

Popular Stocks